Your Location：
Home >
Browse articles >
Alleviating mitochondrial dysfunction in diabetic cardiomyopathy through the Adipsin and Irak2 pathways
COMMENTARY | Updated：2025-12-13

    • Alleviating mitochondrial dysfunction in diabetic cardiomyopathy through the Adipsin and Irak2 pathways

    • “In the field of xxx, expert xx has made significant research progress. They established the xx system/explored the xx topic/verified the xx conjecture, offering solutions to tackle xx problems and paving the way for future research in xx.”
    • Military Medical Research   Vol. 12, Issue 4, Pages: 633-635(2025)

    • DOI：10.1186/s40779-024-00513-y    

      CLC：

    • Published：2025-04

    Scan QR Code

  • Cite this article as: Cummins ML, Delmonte G, Wechsler S, Schlesinger JJ. Alleviating mitochondrial dysfunction in diabetic cardiomyopathy through the Adipsin and Irak2 pathways. Mil Med Res. 2024;11(1):11. DOI： 10.1186/s40779-024-00513-y.

  •  
  •  

0

Views

0

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Adipsin inhibits Irak2 mitochondrial translocation and improves fatty acid β-oxidation to alleviate diabetic cardiomyopathy
Interleukin-1 receptor associated kinase 2 is a functional downstream regulator of complement factor D that controls mitochondrial fitness in diabetic cardiomyopathy
Better therapy for combat injury
Kalman Dynamic Adaptive Filtering to Railway Line Measurement Signals of Tilting Train
Research on the Measurement System of the Attack Angle between Wheel and Rail Based on Image Identification

Related Author

Yang Cao
Dong-Dong Sun
Xuan Zhang
Xiao-Ming Gu
Cong-Ye Li
Xiao Zhang
Hao Wang
Lei Xin

Related Institution

Department of Cardiology, Xijing Hospital, Air Force Medical University
Department of Basic Medicine, Air Force Medical University
Department of Physiology and Pathophysiology, Air Force Medical University
Institute for Hospital Management Research, Chinese PLA General Hospital
Department of Medicine, Fleischer Institute for Diabetes and Metabolism (FIDAM), Einstein-Mount Sinai Diabetes Research Center (ES-DRC), Einstein Institute for Aging Research, Albert Einstein College of Medicine
0